Related Experiment Video

Updated: Mar 16, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K

CIP2A regulates proliferation and apoptosis of multiple myeloma cells

Zhuanzhen Zheng1, Zhenhua Qiao1, Wenliang Chen1

  • 1Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.

Molecular Medicine Reports
|August 4, 2016
PubMed

Insights

Cancerous inhibitor of protein phosphatase 2A (CIP2A) is elevated in multiple myeloma (MM). Silencing CIP2A inhibits MM cell proliferation and induces apoptosis, suggesting CIP2A as a potential therapeutic target for MM.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Multiple myeloma (MM) is a significant cause of cancer mortality in China.
  • The role of cancerous inhibitor of protein phosphatase 2A (CIP2A) in MM progression is currently unknown.

Purpose of the Study:

  • To investigate the expression and molecular mechanism of CIP2A in MM.
  • To evaluate the therapeutic potential of targeting CIP2A in MM.

Main Methods:

  • Quantitative reverse transcription PCR was used to detect CIP2A expression in MM patients and cell lines.
  • Short hairpin RNA was employed to silence CIP2A in RPMI-8226 MM cells.
  • Cell proliferation and apoptosis assays were performed to assess the impact of CIP2A knockdown.

Main Results:

  • CIP2A expression was significantly higher in MM patients and cell lines compared to controls.
  • Silencing CIP2A inhibited the proliferation of RPMI-8226 cells in vitro.
  • CIP2A knockdown led to increased apoptosis and reduced c-Myc protein levels in MM cell lines.

Conclusions:

  • CIP2A plays a role in promoting MM cell growth and survival.
  • Inhibition of CIP2A demonstrates potential as a novel therapeutic strategy for multiple myeloma.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

893
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K